Posts

FDA greenlights first over-the-counter birth control pill

The non-age-restricted pill is expected to roll out early in 2024, and will ‘low...

Actimed plans trials to treat muscle wasting syndrome i...

The company aims to start two trials in H1 2024 based on its current timeline, d...

NVIDIA invests $50m in AI-enabled drug discovery

NVIDIA signed an investment and collaboration agreement with Recursion to create...

Aridis’s AR-301 monoclonal antibody to receive FDA QIDP...

US FDA granted the IgG1 monoclonal antibody the first qualified infectious disea...

Ending racial health disparities hinges on penalties, p...

Health equity experts say public and financial accountability, solutions-based r...

A young girl’s custom gene therapy hints at a framework...

A Boston Children’s Hospital team has developed a second personalized medicine, ...

STAT+: Pharmalittle: EU fines Illumina $475M for closin...

Supplies are running out for dimercaprol, a key antidote for life-threatening le...

STAT+: Europe issues maximum antitrust fine of $475 mil...

The European Union on Wednesday issued an antitrust fine of $475 million to the ...

One year into 988 hotline, staff push for fixes to ambi...

From routing issues to unpredictable call volumes, staff say they’re proud of ho...

STAT+: How to ‘break the logjam’? Economists pitch a pl...

One way to blunt future drug shortages, the economists suggest, is to rework how...

STAT+: How are insurers handling the Alzheimer’s drug L...

A week after the FDA granted full, traditional approval to a new Alzheimer’s tre...

Listen: One Duchenne patient’s bittersweet hope for new...

Hawken Miller joined the "First Opinion Podcast" this week to discuss how Sarept...

Opinion: Sickle cell cures are coming. African children...

Pharmaceutical companies, governments, and the global health care community must...

Superbugs, antibiotic resistance get renewed scrutiny i...

At a Senate subcommittee hearing Tuesday, members discussed reforms that might a...

Takeda withdraws application for dengue vaccine from FDA

Takeda announced that it has voluntarily withdrawn its application to the FDA fo...

A new study of sick infants sees potential in DNA seque...

A new report resurfaces a thorny challenge in researchers’ quest to turn DNA int...